China Oncology Drugs Market Research Report 2018

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,400	120 Pages	QYResearch Group	December, 2018	QYR15844412

Best Price Guarantee
Price	from $3,400
Length	120 Pages
Publisher	QYResearch Group
Published Date	December, 2018
SKU	QYR15844412

China Oncology Drugs Market Research Report 2018

Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others.

In the last several years, China market of Oncology Drugs developed fluctuation, with an average growth rate of 12.72%. In 2017, China Revenue of Oncology Drugs is nearly 13746 M USD and will growth at CAGR at 10% in 2025 the market size will be 29668 M USD.

This report studies the Oncology Drugs development status and future trend in China, focuses on top players in China, also splits Oncology Drugs by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.
Roche
HENGRUI
AstraZeneca
QILU
Sanofi
HANSOH
LUYE
Novartis
GuiZhou YiBai
Lunan
Eli Lilly and Company
Other

Geographically, this report splits the China market into six regions,
South China
East China
Southwest China
Northeast China
North China
Central China
Northwest China

On the basis of product, the Oncology Drugs market is primarily split into
Antimetabolite
Alkaloid drugs
Hormone
Targeted drug
Platinum-based drugs
Other

On the basis on the end users/applications, this report covers
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory/Lung Cancer
Other

1 Oncology Drugs Overview: 1.1 Product Overview and Scope of Oncology Drugs; 1.2 Classification of Oncology Drugs by Product Category; 1.2.1 China Oncology Drugs Revenue Comparison by Types (2013-2025); 1.2.2 China Oncology Drugs Revenue Market Share by Types in 2017; 1.2.3 Antimetabolite; 1.2.4 Alkaloid drugs; 1.2.5 Hormone; 1.2.6 Targeted drug; 1.2.7 Platinum-based drugs; 1.3 China Oncology Drugs Market by Applications/End Users; 1.3.1 China Oncology Drugs Revenue and Market Share Comparison by Applications (2013-2025); 1.3.2 Blood Cancer; 1.3.3 Breast Cancer; 1.3.4 Gastrointestinal Cancer; 1.3.5 Prostate Cancer; 1.3.6 Respiratory/Lung Cancer; 1.4 China Oncology Drugs Market by Regions; 1.4.1 China Oncology Drugs Market Size Comparison by Regions (2013-2025); 1.4.2 South China Oncology Drugs Status and Prospect (2013-2025); 1.4.3 East China Oncology Drugs Status and Prospect (2013-2025); 1.4.4 Southwest China Oncology Drugs Status and Prospect (2013-2025); 1.4.5 Northeast China Oncology Drugs Status and Prospect (2013-2025); 1.4.6 North China Oncology Drugs Status and Prospect (2013-2025); 1.4.7 Central China Oncology Drugs Status and Prospect (2013-2025); 1.4.8 Northwest China Oncology Drugs Status and Prospect (2013-2025); 1.5 China Market Size) of Oncology Drugs (2013-2025); 1.6 Macroscopic Indicator; 1.6.1 GDP for Major Regions; 1.6.2 Population and Labor Considered for Forecast; 1.6.3 Disposable Income Considered for Forecast
2 China Oncology Drugs Market Competition by Players/Manufacturers: 2.1 China Oncology Drugs Revenue and Share by Players/Manufacturers (2017-2018); 2.2 China Oncology Drugs Gross Margin by Players/Manufacturers (2017-2018); 2.3 China Oncology Drugs Market Competitive Situation and Trends; 2.3.1 China Oncology Drugs Market Concentration Rate; 2.3.2 China Oncology Drugs Market Share of Top 5 and Top 5 Players/Manufacturers; 2.3.3 Mergers & Acquisitions, Expansion in China Market; 2.4 China Players/Manufacturers Oncology Drugs Headquarters, Established Date, Product Types
3 China Oncology Drugs Revenue by Regions (2013-2018): 3.1 China Oncology Drugs Revenue and Market Share by Regions (2013-2018); 3.2 China Oncology Drugs Growth Rate by Regions (2013-2018)
4 China Oncology Drugs Revenue by Type/ Product Category (2013-2018): 4.1 China Oncology Drugs Revenue and Market Share by Type (2013-2018); 4.2 China Oncology Drugs Growth Rate by Type (2013-2018)
5 China Oncology Drugs Revenue by Application (2013-2018): 5.1 China Oncology Drugs Revenue and Market Share by Applications (2013-2018); 5.2 China Oncology Drugs Sales Growth Rate by Applications (2013-2018); 5.3 Market Drivers and Opportunities
6 Analysis of Oncology Drugs Industry Key Manufacturers: 6.1 Roche; 6.1.1 Company Profile; 6.1.2 Product Information; 6.1.3 Revenue, Gross Margin and Market Share; 6.2 HENGRUI; 6.2.1 Company Profile; 6.2.2 Product Information; 6.2.3 Revenue, Gross Margin and Market Share; 6.3 AstraZeneca; 6.3.1 Company Profile; 6.3.2 Product Information; 6.3.3 Revenue, Gross Margin and Market Share; 6.4 QILU; 6.4.1 Company Profile; 6.4.2 Product Information; 6.4.3 Revenue, Gross Margin and Market Share; 6.5 Sanofi; 6.5.1 Company Profile; 6.5.2 Product Information; 6.5.3 Revenue, Gross Margin and Market Share; 6.6 HANSOH; 6.6.1 Company Profile; 6.6.2 Product Information; 6.6.3 Revenue, Gross Margin and Market Share; 6.7 LUYE; 6.7.1 Company Profile; 6.6.2 Product Information; 6.7.3 Revenue, Gross Margin and Market Share; 6.8 Novartis; 6.8.1 Company Profile; 6.8.2 Product Information; 6.8.3 Revenue, Gross Margin and Market Share; 6.9 GuiZhou YiBai; 6.9.1 Company Profile; 6.9.2 Product Information; 6.9.3 Revenue, Gross Margin and Market Share; 6.10 Lunan; 6.10.1 Company Profile; 6.10.2 Product Information; 6.10.3 Revenue, Gross Margin and Market Share; 6.11 Eli Lilly and Company; 6.11.1 Company Profile; 6.11.2 Product Information; 6.11.3 Revenue, Gross Margin and Market Share
7 Oncology Drugs Manufacturing Cost Analysis: 7.1 Oncology Drugs R&D Cost Analysis; 7.1.1Clinical Phase Costs; 7.1.2 Capitalized Costs; 7.2 Proportion of Manufacturing Cost Structure; 7.2.1 Raw Materials; 7.2.2 Labor Cost; 7.2.3 Other Costs Analysis; 7.3 Manufacturing Process Analysis of Oncology Drugs
8 Industrial Chain, Sourcing Strategy and Downstream Buyers: 8.1 Oncology Drugs Industrial Chain Analysis; 8.2 Upstream Raw Materials Sourcing; 8.3 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders: 9.1 Marketing Channel; 9.1.1 Direct Marketing; 9.1.2 Indirect Marketing; 9.1.3 Marketing Channel Development Trend; 9.2 Market Positioning; 9.2.1 Pricing Strategy; 9.2.2 Brand Strategy
10 Factors Influencing: 10.1 Price Trend of Key Industrial Raw Material; 10.2 Imports & Exports
11 China Oncology Drugs Market Size Forecast (2019-2025): 11.1 China Oncology Drugs Revenue Forecast (2019-2025); 11.2 China Oncology Drugs Revenue Forecast by Type (2019-2025); 11.3 China Oncology Drugs Revenue Forecast by Application (2019-2025); 11.4 China Oncology Drugs Revenue Forecast by Regions (2019-2025)
12 Research Findings and Conclusion
13 Methodology and Data Source: 13.1 Methodology/Research Approach; 13.1.1 Research Programs/Design; 13.1.2 Market Size Estimation; 13.1.3 Market Breakdown and Data Triangulation; 13.2 Data Source; 13.2.1 Secondary Sources; 13.2.2 Primary Sources; 13.3 Author List; 13.4 Disclaimer
List of Tables and Figures: Figure Product Picture of Oncology Drugs; Figure China Oncology Drugs Revenue (M USD) Comparison by Types (2013-2025); Figure China Oncology Drugs Revenue Market Share by Types; Figure Antimetabolite Product Picture; Figure Alkaloid drugs Product Picture; Figure Hormone Product Picture; Figure Targeted drug Product Picture; Figure Platinum-based drugs Product Picture; Figure China Oncology Drugs Revenue (M USD) Comparison by Applications (2013-2025); Figure China Sales Market Share (%) of Oncology Drugs by Applications in 2017; Figure Blood Cancer Examples; Figure Breast Cancer Examples; Figure Gastrointestinal Cancer Examples; Figure Prostate Cancer Examples; Figure Respiratory/Lung Cancer Examples; Figure China Oncology Drugs Revenue (M USD) Comparison by Regions (2013-2025); Figure South China Oncology Drugs Revenue (M USD) and Growth Rate (2013-2025); Figure East China Oncology Drugs Revenue (M USD) and Growth Rate (2013-2025); Figure Southwest China Oncology Drugs Revenue (M USD) and Growth Rate (2013-2025); Figure Northeast China Oncology Drugs Revenue (M USD) and Growth Rate (2013-2025); Figure North China Oncology Drugs Revenue (M USD) and Growth Rate (2013-2025); Figure Central China Oncology Drugs Revenue (M USD) and Growth Rate (2013-2025); Figure Northwest China Oncology Drugs Revenue (M USD) and Growth Rate (2013-2025); Figure China Oncology Drugs Revenue (M USD) and Growth Rate (2013-2025); Figure GDP for Major Regions in 2016; Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060; Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016; Figure Saving Rate Total, % of GDP, 2015; Figure Forecast of Global Middle-Class Population, 2015 to 2030; Figure Fertility Rates per Woman, 1970 to 2015; Figure Average Years of Schooling of the Adult Population; Figure Household Disposable Income Gross adjusted, US dollars/capita, 2016; Figure Household Spending Total, Million US dollars, 2015; Figure Net National Income Total, US dollars/capita, 2017; Table China Oncology Drugs Revenue (M USD) by Players/Manufacturers (2017-2018); Table China Oncology Drugs Revenue Market Share (%) by Players/Manufacturers (2017-2018); Figure 2017 China Oncology Drugs Revenue Market Share (%) by Players/Manufacturers; Figure 2018 China Oncology Drugs Revenue Market Share (%) by Players/Manufacturers; Table China Market Oncology Drugs Gross Margin of Key Players/Manufacturers (2017-2018); Figure China Market Oncology Drugs Gross Margin of Key Players/Manufacturers in 2017; Figure 2017 China Oncology Drugs Revenue Market Share (%) by Players/Manufacturers; Figure China Oncology Drugs Market Share of Top 5 Players/Manufacturers; Figure China Oncology Drugs Market Share of Top 10 Players/Manufacturers; Table China Players/Manufacturers Oncology Drugs Headquarters and Established Date; Table China Players/Manufacturers Oncology Drugs Product Category; Table China Oncology Drugs Revenue (M USD) and Market Share by Regions (2013-2018); Table China Oncology Drugs Revenue Market Share (%) by Regions (2013-2018); Figure China Oncology Drugs Revenue Market Share (%) by Regions (2013-2018); Figure China Oncology Drugs Revenue Market Share (%) by Regions in 2017; Table China Oncology Drugs Growth Rate by Regions (2013-2018); Table China Oncology Drugs Revenue (M USD) and Market Share by Type (2013-2018); Table China Oncology Drugs Revenue Market Share (%) by Type (2013-2018); Figure Revenue Market Share of Oncology Drugs by Type (2013-2018); Figure Revenue Market Share of Oncology Drugs by Type in 2017; Table China Oncology Drugs Growth Rate by Types (2013-2018); Figure China Oncology Drugs Sales Growth Rate by Type (2013-2018); Table China Oncology Drugs Revenue (M USD) by Applications (2013-2018); Table China Oncology Drugs Sales Market Share (%) by Applications (2013-2018); Figure China Oncology Drugs Sales Market Share (%) by Applications (2013-2018); Figure China Oncology Drugs Sales Market Share (%) by Applications in 2017; Table China Oncology Drugs Sales Growth Rate by Applications (2013-2018); Figure China Oncology Drugs Sales Growth Rate (%) by Applications (2013-2018); Figure Cancer Incidence by Country in 2014; Figure Cancer Mortality by Country in 2014; Figure China Cancer Incidence by Type; Table Roche Company Profile; Figure Oncology Drugs Product Picture of Roche; Table Oncology Drugs Revenue (M USD), Gross Margin and Market Share of Roche 2017-2018; Table HENGRUI Company Profile; Figure Oncology Drugs Product Picture of HENGRUI; Table Oncology Drugs Revenue (M USD), Gross Margin and Market Share of HENGRUI 2017-2018; Table AstraZeneca Company Profile; Figure Oncology Drugs Product Picture of AstraZeneca; Table Oncology Drugs Revenue (M USD), Gross Margin and Market Share of AstraZeneca 2017-2018; Table QILU Company Profile; Figure Oncology Drugs Product Picture of QILU; Table Oncology Drugs Revenue (M USD), Gross Margin and Market Share of QILU 2017-2018; Table Sanofi Company Profile; Figure Oncology Drugs Product Picture of Sanofi; Table Oncology Drugs Revenue (M USD), Gross Margin and Market Share of Sanofi 2017-2018; Table HANSOH Company Profile; Figure Oncology Drugs Product Picture of HANSOH; Table Oncology Drugs Revenue (M USD), Gross Margin and Market Share of HANSOH 2017-2018; Table LUYE Company Profile; Figure Oncology Drugs Product Picture of LUYE; Table Oncology Drugs Revenue (M USD), Gross Margin and Market Share of LUYE 2017-2018; Table Novartis Company Profile; Figure Oncology Drugs Product Picture of Novartis; Table Oncology Drugs Revenue (M USD), Gross Margin and Market Share of Novartis 2017-2018; Table GuiZhou YiBai Company Profile; Figure Oncology Drugs Product Picture of GuiZhou YiBai; Table Oncology Drugs Revenue (M USD), Gross Margin and Market Share of GuiZhou YiBai 2017-2018; Table Lunan Company Profile; Figure Oncology Drugs Product Picture of Lunan; Table Oncology Drugs Revenue (M USD), Gross Margin and Market Share of Lunan 2017-2018; Table Eli Lilly and Company Company Profile; Figure Oncology Drugs Product Picture of Eli Lilly and Company; Table Oncology Drugs Revenue (M USD), Gross Margin and Market Share of Eli Lilly and Company 2017-2018; Figure typical phases from research to the market for a drug candidate; Table Out-of-pocket Preclinical and Clinical Period Cost per Investigational Biopharmaceutical Compound; Table Capitalized Preclinical and Clinical Period costs per Investigational Biopharmaceutical Compound; Figure Manufacturing Cost Structure of Oncology Drugs; Figure USA Labor Cost Analysis 2013-2018; Figure Cost of Employing a Factory Worker; Figure 2016 Estimated Labour Costs for the Whole Economy in Europe; Figure Monthly Minimum Wages in Asia 2016; Figure China Labor Costs 2013-2016; Table Average Price of Electricity to Ultimate Customers 2007-2016; Figure Electricity Prices for Household Consumers in 2016; Figure Summary of the Driving Assumptions; Figure Industrial Electric Rates 2016 (PER KWH); Figure Manufacturing Process Analysis of Oncology Drugs; Figure Oncology Drugs Industrial Chain Analysis; Table Major Buyers of Oncology Drugs; Figure Marketing Channel for Biopharmaceuticals; Figure Conceptual Model of the Flow of Products, Services and Funds for Non-specialty Drugs Coveredunder Private Insurance and Purchased in a Retail Setting; Figure Marketing Channel for Biopharmaceuticals; Figure Setting Pricing Policy; Figure Price Trend of Crude Oil (USD/BBL); Figure Price Trend of Brent Crude Oil (USD/BBL); Figure Price Trend of Natural Gas (MMBtu); Figure Price Trend of Gasoline (GAL)